Shareholders in China National Accord Medicines (SZSE:000028) Are in the Red If They Invested a Year Ago

While not a mind-blowing move, it is good to see that the China National Accord Medicines Corporation Ltd. (SZSE:000028) share price has gained 14% in the last three months. But in truth the last y

Simply Wall StApr 29 20:00 ET

SDIC Securities: The industry is heavily state-owned capital, and the trend of mergers and acquisitions of pharmaceutical distribution companies is expected to accelerate further in 24 years

The new round of state-owned enterprise reform also emphasizes specialized integration in the medical and health sector. The pharmaceutical distribution industry is heavily state-owned and driven by superposition policies. At the time point of 2024, the trend of mergers and acquisitions of domestic pharmaceutical distribution companies is expected to further accelerate.

Zhitong FinanceApr 24 23:22 ET

Sinopharm Holdings (01099): Sinopharm (000028.SZ)'s 2023 net profit of 1,599 billion yuan increased 7.57% year-on-year

Sinopharm Holdings (01099) issued an announcement. Sinopharm Group, a subsidiary of the company, is united Pharmaceutical Co., Ltd. (Sinopharm 1...

Zhitong FinanceApr 7 06:47 ET

Sinopharm Holdings: Sinopharm's consistent annual net profit of 1,599 billion yuan increased 7.57% year-on-year

Sinopharm Holdings (01099) released Sinopharm's consistent (000028.SZ) annual performance report. The company achieved operating income of RMB 75.477 billion (same unit), up 2.77% year on year; operating profit of 2,467 billion yuan, up 7.00% year on year; total profit of 2,473 billion yuan, up 7.02% year on year; net profit attributable to shareholders of listed companies was 1,599 billion yuan, up 7.57% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,533 billion yuan, up 7.58% year on year; basic per share Earnings were 2.87 yuan.

新浪港股Mar 14 21:06 ET

Sinopharm (000028.SZ) performance report: 2023 net profit of 1,599 billion yuan increased 7.57% year-on-year

Gelonghui, March 14 | Sinopharm (000028.SZ) announced its 2023 annual results report. During the reporting period, the company achieved operating income of 75.477 billion yuan, up 2.77% year on year; total profit of 2,467 billion yuan, up 7.00% year on year; total profit of 2,473 billion yuan, up 10.54% year on year; net profit attributable to shareholders of listed companies was 1,598 billion yuan, up 7.57% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss 1,533 billion, a year-on-year increase

Gelonghui FinanceMar 14 06:43 ET

Is China National Accord Medicines Corporation Ltd.'s (SZSE:000028) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Most readers would already be aware that China National Accord Medicines' (SZSE:000028) stock increased significantly by 13% over the past three months. Given that stock prices are usually aligned w

Simply Wall StMar 8 18:21 ET